Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Higher Part D Rebates "Inappropriate" Source Of Funding To Close Donut Hole, Baucus Says

This article was originally published in The Pink Sheet Daily

Executive Summary

During Sept. 24 markup of health reform legislation. Senate Finance Committee defeats an amendment by Sen. Nelson to mandate higher rebates on drugs for dual eligible beneficiaries covered by Medicare Part D.

You may also be interested in...



Senators Consider Fees On PBMs To Help Close Donut Hole

Pharmacy benefit management companies are objecting to an idea that an annual fee on PBMs could be levied to go towards eliminating the Medicare Part D gap in drug coverage.

Senators Consider Fees On PBMs To Help Close Donut Hole

Pharmacy benefit management companies are objecting to an idea that an annual fee on PBMs could be levied to go towards eliminating the Medicare Part D gap in drug coverage.

Bill Thomas' Battle Plan For Cutting Biologics' 12-Year Exclusivity

The former chairman of the House Ways and Means Committee explains how Senate floor debate is key to forcing revisions in the FOB provisions of the health care reform legislation.

Related Content

Topics

UsernamePublicRestriction

Register

MT142539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel